Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Wiener klinische Wochenschrift
A WeltermannR Zweiker

Abstract

In any type of invasive surgery, the patient's individual risk of thromboembolism has to be weighed against the risk of bleeding. Based on various everyday situations in clinical routine, the purpose of the present expert recommendations is to provide appropriate perioperative and periinterventional management for patients with atrial fibrillation undergoing long-term treatment with the thrombin inhibitor dabigatran. As we currently have no routine laboratory test to measure therapeutic levels of the substance or the risk of bleeding, general measures such as a standardized documentation of the patient's history, a sufficient time interval between the last preoperative dose and the procedure, and careful control of local hemostasis should be given special attention.

References

May 25, 2002·Gastrointestinal Endoscopy·Glenn M EisenUNKNOWN American Society for Gastrointestinal Endoscopy
Feb 25, 2005·Gastrointestinal Endoscopy·Marc J ZuckermanUNKNOWN Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy
May 13, 2008·Gut·A M VeitchUNKNOWN British Cardiovascular Intervention Society
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Jan 1, 2010·The New England Journal of Medicine·Donald Stuart Houston, Ryan Zarychanski
Aug 31, 2010·European Heart Journal·UNKNOWN Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for CardDavid Taggart
Nov 25, 2011·The New England Journal of Medicine·Bryan A CottonJohn B Holcomb

❮ Previous
Next ❯

Citations

Nov 13, 2013·Wiener klinische Wochenschrift·Dietmar FriesAnsgar Weltermann
Sep 5, 2013·Wiener medizinische Wochenschrift·Heinrich Wolfgang ThalerMarkus Gosch
Nov 10, 2013·Wiener medizinische Wochenschrift·Ernst J MüllerHeinrich W Thaler
Jul 13, 2013·Thrombosis and Haemostasis·R FerrandisL M Torres
May 16, 2014·Wiener klinische Wochenschrift·Ingrid Pabinger-FaschingReinhard Windhager
Nov 21, 2014·Wiener klinische Wochenschrift·Matthias HasunFranz Weidinger
Jul 13, 2013·Wiener klinische Wochenschrift·Hana Matejovska KubesovaJan Matejovsky
May 28, 2014·Seminars in Hematology·Sibylle A Kozek-Langenecker
Apr 20, 2016·Zeitschrift für Gerontologie und Geriatrie·Thomas J Luger, Markus F Luger
May 14, 2017·Der Anaesthesist·Markus F Luger, Thomas J Luger

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Software Mentioned

RE

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists
Betty C ChenLewis S Nelson
Hospital Pharmacy
S Alexander Winans, Adetola Ademolu
Clinical Chemistry and Laboratory Medicine : CCLM
W M HalbmayerAndrea Griesmacher
World Neurosurgery
Jennifer E FugateGiuseppe Lanzino
© 2021 Meta ULC. All rights reserved